Newsroom

Houston Methodist researchers identified a key protein as a potential therapeutic target for stopping the body’s immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and allergies. The study appeared in the Journal of Clinical Investigation. Read more. 

Houston Methodist researchers have discovered that certain components of so-called “good” cholesterol -- high-density lipoproteins (HDL) – may be associated with an increased prevalence of cardiovascular disease. The research team describe their findings in the American Society for Biochemistry and Molecular Biology’s Journal of Lipid Research. Read more.